Sugi Predict

Sugi Predict / Compounds / SCHEMBL3758938

SCHEMBL3758938

SCHEMBL3758938

Nc1ccccc1-c1[c]nccc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 6/20 0.46
▸ L3MBTL1 Q9Y468 2/20 0.46
▸ HSD17B10 Q99714 3/20 0.40
▸ IDO1 P14902 4/20 0.35
▸ ATAD2 Q6PL18 1/20 0.35
▸ SMN1; SMN2 Q16637 5/20 0.35
▸ CYP3A4 P08684 1/20 0.35
▸ ALOX15 P16050 1/20 0.35
▸ CASP1 P29466 1/20 0.35
▸ CASP7 P55210 1/20 0.35
▸ DCUN1D1 Q96GG9 1/20 0.34
▸ KDM4E B2RXH2 5/20 0.33
▸ NPC1 O15118 4/20 0.33
▸ GAA P10253 4/20 0.33
▸ RAB9A P51151 3/20 0.33
▸ MAPT P10636 2/20 0.33
▸ TDP1 Q9NUW8 2/20 0.33
▸ HPGD P15428 2/20 0.33
▸ NPSR1 Q6W5P4 2/20 0.33
▸ MEN1 O00255 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3763684 0.79 GAA (0.32) ALDH1A1SMN1; SMN2CYP3A4KDM4EGAA
SCHEMBL3763021 0.77 MMP2 (0.34) ALDH1A1L3MBTL1HSD17B10CYP3A4ALOX15
SCHEMBL3751745 0.76 IDO1 (0.41) ALDH1A1L3MBTL1HSD17B10IDO1SMN1; SMN2
SCHEMBL1968471 0.76 NISCH (0.38) ALDH1A1L3MBTL1IDO1DCUN1D1KDM4E
SCHEMBL3759979 0.76 NPC1 (0.39) ALDH1A1L3MBTL1HSD17B10IDO1SMN1; SMN2
SCHEMBL1965907 0.76 CYP2A6 (0.40) ALDH1A1HSD17B10IDO1SMN1; SMN2DCUN1D1
SCHEMBL1201536 0.76 DPP4 (0.46) —
SCHEMBL4909130 0.75 — —
SCHEMBL1200639 0.74 CSNK1A1 (0.51) ALDH1A1HSD17B10SMN1; SMN2CYP3A4KDM4E
SCHEMBL1115099 0.73 NISCH (0.41) ALDH1A1L3MBTL1HSD17B10SMN1; SMN2CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2029570-B1 FUSED THIOPHENE DERIVATIVES AS KINASE INHIBITORS UCB PHARMA SA (BE) 2014-10-15 — — EP disclosed
US-8324204-B2 Fused thiophene derivatives as kinase inhibitors UCB PHARMA SA (BE) 2012-12-04 — — US disclosed
US-20100305066-A1 Fused Thiophene Derivatives as Kinase Inhibitors UCB PHARMA S.A. (BE) 2010-12-02 — — US disclosed
WO-2009122148-A1 FUSED THIOPHENE AND THIAZOLE DERIVATIVES AS PI3K KINASE INHIBITORS UCB PHARMA S.A. (BE) 2009-10-08 — — WO disclosed
WO-2009071890-A1 TRICYCLIC KINASE INHIBITORS UCB PHARMA S.A. (BE) 2009-06-11 — — WO disclosed
WO-2009071895-A1 FUSED THIAZOLE AND THIOPHENE DERIVATIVES AS KINASE INHIBITORS UCB PHARMA S.A. (BE) 2009-06-11 — — WO disclosed
EP-2029570-A1 FUSED THIOPHENE DERIVATIVES AS KINASE INHIBITORS UCB Pharma S.A. (BE) 2009-03-04 — — EP disclosed
WO-2007141504-A1 FUSED THIOPHENE DERIVATIVES AS KINASE INHIBITORS UCB PHARMA S.A. (BE) 2007-12-13 — — WO disclosed
WO-2005112925-A1 ARYL SULFONAMIDES CHEMOCENTRYX (US) 2005-12-01 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100305066-A1 Fused Thiophene Derivatives as Kinase Inhibitors PIKFYVE, PI4KA, PIK3CA ALDH1A1 3061/4885L3MBTL1 1887/4885HSD17B10 2922/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.